TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32291984

Group type: EXPERIMENTAL
Intervention: Anatomical calcaneal external fixator designed based on morphological data of the heel.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ordinary configuration of the external fixator.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Compression configuration of the external fixator.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Orthodontic configuration of the external fixator.
Number of subjects: 100
Study: 35662232

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg/d for 12 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no ramipril)
Number of subjects: 37
Study: 34881910

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 80
Study: 35745238

Group type: EXPERIMENTAL
Intervention: Calorie-restricted (CR) diet for twelve weeks (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 60
Study: 34287695

Group type: EXPERIMENTAL
Intervention: Intervention (open, endovascular, and stereotactic surgeries)
Number of subjects: 40285

Group type: EXPERIMENTAL
Intervention: Intervention (open surgery)
Number of subjects: 40285

Group type: EXPERIMENTAL
Intervention: Intervention (endovascular and stereotactic surgeries)
Number of subjects: 40285

Group type: EXPERIMENTAL
Intervention: Intervention (admissions involving interventions)
Number of subjects: 40285

Group type: EXPERIMENTAL
Intervention: Intervention (length of stay)
Number of subjects: 40285
Study: 32075835

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 42
Study: 34403561

Group type: EXPERIMENTAL
Intervention: Blended learning
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional teaching
Number of subjects: 72
Study: 33541457

Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 918

Group type: COMPARATOR
Intervention: MCV4-TT
Number of subjects: 918
Study: 32602032

Group type: EXPERIMENTAL
Intervention: 68Ga‐DOTATATE PET‐CT
Number of subjects: 38

Group type: COMPARATOR
Intervention: CI
Number of subjects: 38
Study: 36107655

Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natural viewing
Number of subjects: 0
Study: 34213978

Group type: EXPERIMENTAL
Intervention: Medicaid expansion
Number of subjects: 196556
Study: 32362166

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 34116625

Group type: EXPERIMENTAL
Intervention: Brief intervention about the benefits of perceived control and planning for end-of-life
Number of subjects: 188

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 188
Study: 32196514

Group type: EXPERIMENTAL
Intervention: Microfinance and peer health leadership intervention
Number of subjects: 1258

Group type: COMPARATOR
Intervention: Control condition (brief delayed intervention)
Number of subjects: 1258
Study: 33544983

Group type: EXPERIMENTAL
Intervention: Calcium lactate mouthrinse prior to sodium fluoride mouthrinse
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Daily mouthrinse with sodium fluoride
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (absence of mouthrinse)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 75
Study: 35360477

Group type: EXPERIMENTAL
Intervention: Multimodal analgesic nursing
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine analgesic nursing
Number of subjects: 86
Study: 33656249

Group type: EXPERIMENTAL
Intervention: Reflex zone stimulation (RST) for 30 minutes
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 21
Study: 36067240

Group type: EXPERIMENTAL
Intervention: Stress management intervention
Number of subjects: 151

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 151
Study: 32893767

Group type: EXPERIMENTAL
Intervention: Home-based physical exercise program (two 60-minute sessions per week for 36 weeks, supervised by a personal trainer)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Home-based physical exercise program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (habitual leisure-time activities)
Number of subjects: 48
Study: 33269486

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 14565
Study: 33208164

Group type: EXPERIMENTAL
Intervention: EFLT‐abolishing‐EPAP
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fixed‐EPAP
Number of subjects: 12
Study: 34796778

Group type: EXPERIMENTAL
Intervention: High-intensity KE strength-training
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Low-intensity KE strength-training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 34034754

Group type: EXPERIMENTAL
Intervention: artemether–lumefantrine (AL)
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: artesunate–amodiaquine (ASAQ)
Number of subjects: 449
Study: 32166842

Group type: EXPERIMENTAL
Intervention: Paresthesia mapping (PM)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Anatomical placement (AP)
Number of subjects: 53
Study: 35904639

Group type: EXPERIMENTAL
Intervention: NIR‐AF (Near-infrared autofluorescence)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard practice (Control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NIR‐AF
Number of subjects: 60
Study: 32939028

Group type: EXPERIMENTAL
Intervention: Adaptive trial designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Existing SCI registries
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptive methods
Number of subjects: 0
Study: 35572982

Group type: EXPERIMENTAL
Intervention: CIT/HOMO (citicoline 500 mg plus homotaurine 50 mg) for 4 months
Number of subjects: 57

Group type: COMPARATOR
Intervention: Topical therapy alone for 4 months
Number of subjects: 57
Study: 33591774

Group type: EXPERIMENTAL
Intervention: Slower response speed
Number of subjects: 7565

Group type: COMPARATOR
Intervention: Faster response speed
Number of subjects: 7565

Group type: EXPERIMENTAL
Intervention: Explicit instructions to ignore response speed
Number of subjects: 7565
Study: 32406864

Group type: EXPERIMENTAL
Intervention: Gratitude letter-writing intervention (self-focused)
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Gratitude letter-writing intervention (other-focused)
Number of subjects: 1575

Group type: COMPARATOR
Intervention: Gratitude letter-writing intervention (self-focused vs other-focused)
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Participants with higher motivation to improve EE
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Linguistic analysis of gratitude letters
Number of subjects: 1575
Study: 33979696

Group type: EXPERIMENTAL
Intervention: Individual physiotherapy based on the Bobath concept, lasting about 60 min.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Lecture on the importance of trunk muscle stability and diaphragm position, lasting 45 min.
Number of subjects: 74
Study: 32209449

Group type: EXPERIMENTAL
Intervention: Gallium-68 PSMA-11 PET-CT
Number of subjects: 302

Group type: COMPARATOR
Intervention: Conventional imaging (CT and bone scan)
Number of subjects: 302
Study: 34473768

Group type: EXPERIMENTAL
Intervention: Total sleep deprivation (n = 40)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rested control condition (n = 20)
Number of subjects: 60
Study: 32965617

Group type: EXPERIMENTAL
Intervention: CT-P13 (biosimilar infliximab)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Originator infliximab
Number of subjects: 155
Study: 34587371

Group type: EXPERIMENTAL
Intervention: Liposomal cyclosporine A for inhalation (L‐CsA‐i) administered twice daily via nebulizer for 2 years
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Liposomal cyclosporine A for inhalation (L‐CsA‐i) administered to SLT recipients
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo administered to BLT recipients
Number of subjects: 130
Study: 33616260

Group type: EXPERIMENTAL
Intervention: Oral aripiprazole
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Long-acting antipsychotics
Number of subjects: 300
Study: 33236124

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 0
Study: 36099927

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (nivolumab 1 mg/kg plus ipilimumab 3 mg/kg every 3 weeks for four doses followed by nivolumab 3 mg/kg every 2 weeks)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Nivolumab alone (nivolumab 3 mg/kg every 2 weeks)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 34824169

Group type: EXPERIMENTAL
Intervention: lidocaine with dexmedetomidine 0.5 μg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: lidocaine with dexmedetomidine 1 μg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: lidocaine diluted with normal saline
Number of subjects: 90
Study: 33351126

Group type: EXPERIMENTAL
Intervention: Polyvalent immunoglobulin preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pneumolysin treatment
Number of subjects: 0
Study: 33328218

Group type: EXPERIMENTAL
Intervention: Supervised exercise 3 days/week for 12 weeks (n=28)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Usual care (n=29)
Number of subjects: 57
Study: 32029304

Group type: EXPERIMENTAL
Intervention: Delgocitinib 0.5% ointment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vehicle ointment
Number of subjects: 100
Study: 35078486

Group type: EXPERIMENTAL
Intervention: Radial shockwave on the carpal tunnel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Radial shockwave on the median nerve pathways
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physiotherapy (Control)
Number of subjects: 60
Study: 34185723

Group type: EXPERIMENTAL
Intervention: 5 mL 0.5% ropivacaine (low-volume STB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 15 mL 0.5% ropivacaine (standard-volume STB)
Number of subjects: 0
Study: 32014800

Group type: EXPERIMENTAL
Intervention: Self-care strategies and obstacles
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Frequency of self-care
Number of subjects: 46
Study: 33118702

Group type: COMPARATOR
Intervention: 0% chitosan supplementation
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.1% chitosan supplementation
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.5% chitosan supplementation
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1.0% chitosan supplementation
Number of subjects: 80
Study: 32634275

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 3981

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 3981

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3981
Study: 35793983

Group type: EXPERIMENTAL
Intervention: Dynamic impression lining material (DIL)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional hard denture liner (HL)
Number of subjects: 25
Study: 34246121

Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 398
Study: 32419349

Group type: EXPERIMENTAL
Intervention: Foley catheter
Number of subjects: 49

Group type: COMPARATOR
Intervention: Non-Foley catheter
Number of subjects: 49
Study: 34954840

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 391
Study: 35702007

Group type: EXPERIMENTAL
Intervention: Thermal capacitive-resistive monopolar radiofrequency plus exercising
Number of subjects: 81
Study: 33522019

Group type: EXPERIMENTAL
Intervention: IV and local tranexamic acid (TA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 32851921

Group type: EXPERIMENTAL
Intervention: Continuous neuromuscular blockade (NMB) for 24 hours
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Continuous neuromuscular blockade (NMB)
Number of subjects: 80
Study: 35062899

Group type: EXPERIMENTAL
Intervention: Foot reflexology (10 min of general massage and specific reflexology on uterine, pituitary, and solar plexus points)
Number of subjects: 80

Group type: COMPARATOR
Intervention: General massage (10 min) on a neutral point on the lateral side of the heel
Number of subjects: 80
Study: 34373301

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 33926288

Group type: EXPERIMENTAL
Intervention: Multicomponent reading intervention (MCRI)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 128
Study: 32131077

Group type: EXPERIMENTAL
Intervention: Smartphone overdependence prevention program (8 sessions, twice a week)
Number of subjects: 64
Study: 35237700

Group type: EXPERIMENTAL
Intervention: D/C/F/TAF
Number of subjects: 306

Group type: COMPARATOR
Intervention: DTG/3TC/ABC
Number of subjects: 306
Study: 33870919

Group type: EXPERIMENTAL
Intervention: Earplugs and eye masks in addition to standard postoperative care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 0
Study: 33914158

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injections (3 monthly injections followed by treat-and-extend regimen)
Number of subjects: 48
Study: 33788599

Group type: EXPERIMENTAL
Intervention: Trauma Center Trauma‐Sensitive Yoga (TCTSY); n=58, 10 weekly 60-min group sessions.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT); n=46, 12 weekly 90-min group sessions.
Number of subjects: 104
Study: 35973009

Group type: EXPERIMENTAL
Intervention: Invasive treatment strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 1 MI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procedural MI (primary definition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procedural MI (secondary definition)
Number of subjects: 0
Study: 35398549

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33663939

Group type: EXPERIMENTAL
Intervention: Continuous Saline Bladder Irrigation (CSBI)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control group (no CSBI)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: CSBI
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Mitomycin (MMC)
Number of subjects: 167
Study: 35589025

Group type: EXPERIMENTAL
Intervention: Bring BG Down! intervention group (telehealth sessions for 6 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (only completed questionnaires)
Number of subjects: 0
Study: 33663059

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Liujunzi Decoction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liujunzi Decoction
Number of subjects: 0
Study: 34847780

Group type: EXPERIMENTAL
Intervention: Acupuncture (AG)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 171
Study: 32387523

Group type: EXPERIMENTAL
Intervention: Oxygenation/ventilation strategies
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Standardized management of ARF
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Clinically based primary end points
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Single‐center trials
Number of subjects: 74
Study: 36328403

Group type: EXPERIMENTAL
Intervention: Rehabilitation alone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Delayed ACLR
Number of subjects: 120

Group type: COMPARATOR
Intervention: Early ACLR
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Healed ACL group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-healed group
Number of subjects: 120
Study: 34391294

Group type: EXPERIMENTAL
Intervention: Pilates protocol for 8 weeks, 2 sessions per week
Number of subjects: 44
Study: 32050951

Group type: EXPERIMENTAL
Intervention: Mail reminder
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Telephone reminder
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Combined mail and telephone reminders
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (usual postcards)
Number of subjects: 240
Study: 34172103

Group type: EXPERIMENTAL
Intervention: Dignity therapy (DT)
Number of subjects: 39
Study: 34091572

Group type: EXPERIMENTAL
Intervention: PERN's collaborative research efforts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PERN's global randomized controlled trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prospective observational studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focus on implementation science
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expansion of PERN's global reach
Number of subjects: 0
Study: 32966971

Group type: EXPERIMENTAL
Intervention: Exenatide plus insulin glargine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Insulin lispro plus glargine
Number of subjects: 92
Study: 33124189

Group type: EXPERIMENTAL
Intervention: 360° argon or selective laser trabeculoplasty (LTP)
Number of subjects: 122
Study: 32576561

Group type: EXPERIMENTAL
Intervention: Combination treatment with exenatide (2 mg/week) and pioglitazone (30 mg/day)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Basal-bolus insulin (glargine with aspart)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (baseline only)
Number of subjects: 38
Study: 36180899

Group type: EXPERIMENTAL
Intervention: End-of-life conversation game (Hello)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Nationally utilized workshop format for ACP conversations (The Conversation Project)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Attention control game (TableTopics)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 1500
Study: 34103002

Group type: EXPERIMENTAL
Intervention: Fitbit Charge 3™ (FC3) during metronome-assisted walking at 84 steps per minute
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fitbit Charge 3™ (FC3) during metronome-assisted walking at 100 steps per minute
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fitbit Charge 3™ (FC3) during the 200-m walk
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fitbit Charge 3™ (FC3) during walking at 84 and 100 steps per minute, and stepping-in-place at 100 steps per minute
Number of subjects: 15
Study: 36056908

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided capsular injection of dexamethasone (DEX) and lidocaine
Number of subjects: 73

Group type: COMPARATOR
Intervention: Oral prednisolone (PSL)
Number of subjects: 73
Study: 32050090

Group type: EXPERIMENTAL
Intervention: Accelerated surgery
Number of subjects: 2970

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 2970
Study: 33579718

Group type: EXPERIMENTAL
Intervention: Immediate insertion of the copper IUD (within 24 hours)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Delayed insertion of the copper IUD (3 weeks post-abortion)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Immediate insertion of the copper IUD
Number of subjects: 114

Group type: COMPARATOR
Intervention: Delayed insertion of the copper IUD
Number of subjects: 114
Study: 33624848

Group type: EXPERIMENTAL
Intervention: Child-based cognitive-behavioral therapy (CBT)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Parent-based SPACE (Supportive Parenting for Anxious Childhood Emotions)
Number of subjects: 124
Study: 35471254

Group type: EXPERIMENTAL
Intervention: Integrated nomogram incorporating age, rT-stage, and deep learning PET/CT signature
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Integrated nomogram
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Low-risk patients
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: High-risk patients
Number of subjects: 420
Study: 33160256

Group type: EXPERIMENTAL
Intervention: Educational board game intervention
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 259
Study: 35388730

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 195
Study: 34258935

Group type: EXPERIMENTAL
Intervention: Active transcranial direct stimulation followed by yoga intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham transcranial direct stimulation followed by yoga intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both active and sham transcranial direct stimulation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Active vs. Sham transcranial direct stimulation
Number of subjects: 22
Study: 32451909

Group type: EXPERIMENTAL
Intervention: Sarilumab 200 mg every 2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sarilumab 150 mg every 2 weeks
Number of subjects: 0
Study: 34287622

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Therapy (CBGT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 108
Study: 32500299

Group type: EXPERIMENTAL
Intervention: Multi-component exercise program (high-intensity progressive resistance training at 60-85% max, weight-bearing impact exercise, 3 days/week for 18 months)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Multi-component exercise program
Number of subjects: 180

Group type: COMPARATOR
Intervention: No exercise
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Multi-component exercise program and No exercise
Number of subjects: 180
Study: 32838647

Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: efavirenz 400 mg
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: standard dose regimen (tenofovir disoproxil 200 mg, efavirenz 600 mg and lamivudine)
Number of subjects: 184

Group type: COMPARATOR
Intervention: lower dose regimen (tenofovir disoproxil 200 mg, efavirenz 400 mg and lamivudine)
Number of subjects: 184
Study: 35254032

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0